Arch Therapeutics, Inc. (ARTH)

Other OTC - Other OTC Delayed Price. Currency in USD

Add to watchlist

0.9250

-0.0850

(-8.42%)

At close: 03:58PM EDT

Insider Roster

Individual or Entity	Most Recent Transaction	Date	Shares Owned as of Transaction Date
ABRAMS MICHAEL S Chief Investment Officer	Purchase	Aug 30, 2023	10,292
DAVIS RICHARD E Chief Financial Officer	Stock Award(Grant)	Jul 18, 2018	878,000
DHILLON AVTAR S Former	Stock Award(Grant)	Jul 18, 2018	8,517,370
NORCHI TERRENCE W Chief Executive Officer	Purchase	Aug 30, 2023	6,862
YRIGOYEN DAN Officer	Stock Award(Grant)	Jul 29, 2021	150,000
*Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.